We have located links that may give you full text access.
Inflammatory markers and left ventricular diastolic dysfunction in a family-based population study.
Kardiologia Polska 2018 November 9
BACKGROUND: Heart failure affects patients with normal left ventricular systolic function (heart failure with preserved ejection fraction, HFPEF) and those with reduced ejection fraction (HFREF). The treatment of HFPEF remains an unresolved issue.
AIM: The purpose of this study was to determinate the relationship between inflammatory markers and left ventricular diastolic dysfunction (LVDD) in a family-based population study.
METHODS: In 303 participants from the general population (55% women, median age 49 years and 45% men, median age 40 years) we assessed echocardiography examination and measured inflammatory markers in serum: C-reactive protein (CRP), myeloperoxidase (MPO) and interleukin 6 (IL-6).
RESULTS: The correlation of IL-6 concentration was observed for peak of the transmitral late diastolic velocity (A) and S/D ratio (p<0.01). Moreover significant correlation between IL-6 was shown to have an effect on E/A ratio and early diastolic peak velocities of the mitral annulus displacement (E'). The association of IL-6 concentration was noted with the peak of transmitral early diastolic velocities (E) and the the E/E' ratio (p<0.05) in men. In addition, the CRP concentration was shown to have an effect on E/A ratio in women (p<0.05). Moreover significant correlation between the CRP concentration and S/D ratio was observed in both women (p<0.01) and men (p<0.05). No significant correlation was observed between the level of MPO and LVDD parameters. Additionally only one predictive model for E' was depended on IL-6, age and heart rate in the men was found (p<0.001, R²=0.611).
CONCLUSIONS: The above results suggest that inflammation may lead to the onset of LVDD probably via vascular endothelial dysfunction.
AIM: The purpose of this study was to determinate the relationship between inflammatory markers and left ventricular diastolic dysfunction (LVDD) in a family-based population study.
METHODS: In 303 participants from the general population (55% women, median age 49 years and 45% men, median age 40 years) we assessed echocardiography examination and measured inflammatory markers in serum: C-reactive protein (CRP), myeloperoxidase (MPO) and interleukin 6 (IL-6).
RESULTS: The correlation of IL-6 concentration was observed for peak of the transmitral late diastolic velocity (A) and S/D ratio (p<0.01). Moreover significant correlation between IL-6 was shown to have an effect on E/A ratio and early diastolic peak velocities of the mitral annulus displacement (E'). The association of IL-6 concentration was noted with the peak of transmitral early diastolic velocities (E) and the the E/E' ratio (p<0.05) in men. In addition, the CRP concentration was shown to have an effect on E/A ratio in women (p<0.05). Moreover significant correlation between the CRP concentration and S/D ratio was observed in both women (p<0.01) and men (p<0.05). No significant correlation was observed between the level of MPO and LVDD parameters. Additionally only one predictive model for E' was depended on IL-6, age and heart rate in the men was found (p<0.001, R²=0.611).
CONCLUSIONS: The above results suggest that inflammation may lead to the onset of LVDD probably via vascular endothelial dysfunction.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app